The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study
- Nicholas H. B. Schräder
- , José C. Duipmans
- , Remco J. Renken
- , Peter Sörös
- , Karin M. Vermeulen
- , Maria C. Bolling
- , André P. Wolff
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.